Ophthalmology Advisor
LightNews LightNews
banner
ophthalmologyadv.bsky.social
Ophthalmology Advisor
@ophthalmologyadv.bsky.social
56 followers 250 following 28 posts
Breaking news and clinical information for ophthalmologists and other eye care professionals.
Posts Replies Media Videos
ophthalmologyadv.bsky.social
#AAO2025: Semaglutide, a glucagon-like peptide-1 receptor agonist (#GLP1RA), can elevate some patients’ likelihood of developing ischemic optic neuropathy (#ION) and retinal detachment (#RD) compared with #Tirzepatide.

Read more: https://bit.ly/3JfF9bK

#MedSky #Ophthalmology
GLP-1 RA Use Linked to Retinal Detachment and Ischemic Optic Neuropathy  - Ophthalmology Advisor
Investigators reviewed ocular side effects of semaglutide use from a global population-based study across 180 countries.
bit.ly
October 26, 2025 at 7:48 PM
ophthalmologyadv.bsky.social
#AAO2025: A novel topical agent may offer rapid and sustained relief for patients with #DryEyeDisease, according to research presented at the American Academy of Ophthalmology 2025 annual meeting held in Orlando, FL, October 18 to 20.

Read more: https://bit.ly/3WiIv0B

#Ophthalmology #MedSky
Dry Eye Therapy With TRPM8 Agonist May Lead To Meaningful Long-Term Improvement - Ophthalmology Advisor
In 2 phase 3 studies, acoltremon 0.003% met primary endpoints, demonstrating statistically significant tear production at day 14.
bit.ly
October 25, 2025 at 8:55 PM
ophthalmologyadv.bsky.social
#AAO2025: Treatment with high dose #Aflibercept 8 mg can lead to similar #VisualOutcomes with fewer injections for patients with various #RetinalVeinOcclusion (RVO) subtypes.

Read more: https://bit.ly/4o3qTSp

#Ophthalmology #EyeSky #RVO #MedSky
Retinal Vein Occlusion Subtypes Can Be Treated With High Dose Aflibercept - Ophthalmology Advisor
Researchers compared the use of aflibercept 8 mg and 2 mg in patients with various retinal vein occlusion subtypes.
bit.ly
October 24, 2025 at 8:30 PM
ophthalmologyadv.bsky.social
#AAO2025: Treatment with an intravenously delivered, anti-insulin-like growth factor-1 receptor (IGF-1R) antibody can reduce signs of thyroid eye disease (#TED) and improve quality of life.

Read here: https://bit.ly/3LrozWR

#Ophthalmology #IGF1R #ThyroidEyeDisease
IGF-1R Antibody Reduces Thyroid Eye Disease Signs, Improves Quality of Life - Ophthalmology Advisor
Researchers assessed the quality of life measures of patients with thyroid eye disease treated with Veligrotug, a full antagonist humanized mAb to IGF-1R.
bit.ly
October 24, 2025 at 8:00 PM
ophthalmologyadv.bsky.social
#AAO2025: Even with persistent areas of avascular retina (#PAR) after #AntiVEGF monotherapy, outcomes for patients with #RetinopathyOfPrematurity remain favorable.

Read more: https://bit.ly/4ho41dU

#Ophthalmology #MedSky #EyeSky
Retinopathy of Prematurity Anti-VEGF Monotherapy Outcomes Remain Strong Long Term - Ophthalmology Advisor
Investigators evaluated long-term outcomes for ROP patients with persistent avascular retina initially treated with anti-VEGF injections without laser therapy.
bit.ly
October 24, 2025 at 7:20 PM
ophthalmologyadv.bsky.social
#AAO2025: Long-term follow-up of patients with nonproliferative diabetic retinopathy (#NPDR) enrolled in the #VOYAGE study reveals a concerning pattern of disease progression following completion of #ClinicalTrial care.

Read more: https://bit.ly/4oCLVr6

#Ophthalmology #Retina
Trial Participants’ Vision Worsened 3 Years After Diabetic Retinopathy Treatment Study - Ophthalmology Advisor
Investigators reviewed the long-term outcomes of patients who completed the PANORAMA clinical trial and have since sought standard clinical care.
bit.ly
October 23, 2025 at 9:09 PM
ophthalmologyadv.bsky.social
#AAO2025: Explainable artificial intelligence (#XAI) can identify clinically significant diabetic retinal neurodegeneration (#DRN) on optical coherence tomography (#OCT) images. Presented at the American Academy of Ophthalmology (AAO) 2025 meeting

Read more: https://bit.ly/4oCKmcI

#MedTech #AI
October 23, 2025 at 6:45 PM
ophthalmologyadv.bsky.social
#AAO2025: Despite years of safety campaigns and advances in toy design, the rate of toy-related #OcularInjuries (#TOIs) among children in the U.S. has remained largely unchanged for the past 2 decades

Read more: https://bit.ly/3LoWzTN

#Ophthalmology #MedSky #EyeSafety
October 22, 2025 at 9:00 PM
ophthalmologyadv.bsky.social
#AAO2025: A novel #microRNA eye drop therapeutic option to manage either #DryEyeDisease (DED) or #CornealRepair, or both, may be on the horizon as demonstrated by 2 #ClinicalTrial results.

Read more: https://bit.ly/47m7WmQ

#Ophthalmology #MedSky #EyeSky
MicroRNA Eye Drop Improves Symptoms and Signs of Dry Eye Disease and Corneal Repair - Ophthalmology Advisor
Investigators evaluated the application of a microRNA therapy for both corneal repair and dry eye disease.
bit.ly
October 22, 2025 at 8:29 PM
ophthalmologyadv.bsky.social
#AAO2025: Researchers parsed the risks and types of ocular injuries associated with pickleball. Presented at the American Academy of Ophthalmology (AAO) 2025 conference

Read more: https://bit.ly/4o1iSNQ

#Ophthalmology #MedSky #EyeSky #OcularInjuries #Pickleball
Pickleball-Related Ocular Injuries On The Rise, Experts Champion Protective Eye Wear - Ophthalmology Advisor
Researchers parsed the risks and types of ocular injuries associated with pickleball.
bit.ly
October 21, 2025 at 8:03 PM
ophthalmologyadv.bsky.social
#AAO2025: With a single dose, bioerodible #Vorolanib intravitreal insert may preserve vision and benefit anatomic structures, lengthening treatment duration. Presented at the American Academy of Ophthalmology annual meeting

Read more: https://bit.ly/4hmUZhm

#Ophthalmology #ClinicalTrial #EYP1901
October 21, 2025 at 7:12 PM
ophthalmologyadv.bsky.social
#AAO2025: Certain classes of #HypoglycemicAgents may carry an increased risk for developing #Glaucoma. Presented at American Academy of Ophthalmology.

This @stonybrooku.bsky.social - study was presented by Millen S. Khangura and team.

Read more: https://bit.ly/4hFZKmt

#Ophthalmology #MedSky
Glaucoma Risk Increased for Patients Using SGLT-2 Inhibitors, GLP-1 RA - Ophthalmology Advisor
Researchers evaluated the changes to glaucoma risk for patients using hypoglycemic agents to manage diabetes.
bit.ly
October 21, 2025 at 5:45 PM
ophthalmologyadv.bsky.social
#AAO2025: A sustained-release #Travoprost intracameral implant significantly reduced the need for topical #IOP–lowering medications compared with timolol through 36 months in patients with open-angle #Glaucoma or #OcularHypertension. Presented at AAO 2025.

Read more: https://bit.ly/3L1ELy0

#MedSky
Travoprost Intracameral Implant Reduces Glaucoma Treatment Burden Through 36 Months - Ophthalmology Advisor
Researchers compared the medication burden of an intracameral implant and a topical IOP-lowering drop.
bit.ly
October 20, 2025 at 9:26 PM
ophthalmologyadv.bsky.social
#AAO2025: Investigators conducted a large-scale retrospective cohort study of the prevalence and age of onset of #RetinalDetachment and #Cataracts among patients with #RetinitisPigmentosa. Presented at AAO 2025.

Read here: https://bit.ly/4oxMZwo

#Ophthalmology #MedSky #EyeSky
Early Onset Cataract, Retinal Detachment Risk Higher With Retinitis Pigmentosa - Ophthalmology Advisor
Investigators conducted a large-scale retrospective cohort study of the prevalence and age of onset of retinal detachment and cataracts among patients with retinitis pigmentosa.
bit.ly
October 20, 2025 at 6:56 PM
ophthalmologyadv.bsky.social
#AAO2025: #Foselutoclax can improve best-corrected visual acuities in patients with #DiabeticMacularEdema and #VisualAcuity deficits, despite prior #AntiVEGF treatment. Presented at AAO 2025 by David Eichenbaum, MD, of Retina Vitreous Associates of Florida.

Read more ➡️: bit.ly/4nd34Xa
Foselutoclax Delivers Durable Vision Benefits in Diabetic Macular Edema - Ophthalmology Advisor
Presenters at the AAO discussed phase 2 clinical trial results evaluating the safety and efficacy of foselutoclax (UBX1325) compared with aflibercept in diabetic macular edema.
bit.ly
October 20, 2025 at 5:40 PM
ophthalmologyadv.bsky.social
#ASCRS2025: At the 2025 ASCRS meeting, the top paper presentations on #RefractiveProcedures, as determined by ASCRS, reflected a broad theme of how to leverage technology and advanced techniques to improve outcomes.

Read more: bit.ly/3I7DEeC

#MedSky #Ophthalmology #EyeSky
Modern Refractive Surgery Tools and Techniques Presented at ASCRS Meeting
Fresh lenticule transplantation, pre-LASIK workup, and updated implantable collamer lens techniques are among the topics reviewed at ASCRS.
bit.ly
July 1, 2025 at 8:35 PM
ophthalmologyadv.bsky.social
👁️ Cataract Innovations Take the Spotlight at #ASCRS2025

Posters shared at the ASCRS Annual Meeting show the research behind dropless surgery, light adjustable IOLs, and more.

Read more: bit.ly/4l7Vo89

#MedSky #EyeSky #Ophthalmology
Cataract Surgery Innovations Highlight Postop Drop Efficacy and IOL Tech at ASCRS
The top cataract posters at ASCRS reviewed pre- and postoperative medical eye drops, IOL technologies, and legislative challenges.
bit.ly
June 25, 2025 at 3:50 PM
ophthalmologyadv.bsky.social
🏆#ASCRS2025: Award-Winning Corneal Research

At the 2025 ASCRS Annual Meeting, top #CornealResearch was recognized in a session moderated by Kathryn M. Hatch, MD, and Zeba Syed, MD.

Read more ➡️ : bit.ly/4knbqL6

#Cornea #Ophthalmology #MedSky #EyeSky
Top Corneal Research Poster Winners Talk Through Findings, Complex Cases at ASCRS
The leading corneal research presented at ASCRS offered a glimpse at the subspecialty’s most promising medical and surgical advancements.
bit.ly
June 16, 2025 at 7:00 PM
ophthalmologyadv.bsky.social
#OphthalmologyDx: Diagnose This Disorder on the Double

A 61-year-old woman presented with #BlurryVision and notable findings on #OpticalCoherenceTomography. Can you identify her condition?

Read more: bit.ly/3SNmiG2

#MedSky #EyeSky
Ophthalmology Dx: Diagnose This Disorder on the Double - Ophthalmology Advisor
A 61-year-old woman presented with blurry vision and notable findings on optical coherence tomography. Can you identify her condition?
bit.ly
June 4, 2025 at 6:05 PM
ophthalmologyadv.bsky.social
🌷 Did you catch May's FDA Roundup?

Catch up on the latest from the @fda.gov with regard to #EyeCare products

👁️ 4D-150: Diabetic Macular Edema
👁️ Urcosimod: Neuropathic Corneal Pain
👁️ Luminopia: Amblyopia Aged 8 to 12 Years
👁️ OcuMet Beacon
👁️ Tristel OPH

Read more: bit.ly/40JLdPu

#EyeSky #MedSky
FDA Alerts: Ophthalmology Drug and Device Approvals
FDA alerts and updates on the latest drug and device approvals, recalls, and other regulatory developments in ophthalmology.
bit.ly
June 2, 2025 at 8:00 PM
ophthalmologyadv.bsky.social
#ASCRS2025 presenters offered dozens of findings relevant to #Presbyopia-correcting #IntraocularLenses.

Read more: bit.ly/3SP9vCR

#IOL #Ophthalmology #EyeSky #MedSky
Presbyopia-Correcting Intraocular Lens Research in Abundance At ASCRS 2025
Presbyopia-correcting lens clinical trials and real-world research show the vast escalation of options in the US IOL market.
bit.ly
May 21, 2025 at 6:45 PM
ophthalmologyadv.bsky.social
A variety of research into GLP-1 RAs shows a pattern of adverse #OcularEffects, prompting recommendations for #OphthalmicEvaluations with their use.

Read here: bit.ly/3F7Fb3j

#GLP1 #EyeSky #MedSky #T2DM #OpticNeuropathy
Optic Neuropathy and Other Hidden Ocular Risks of GLP-1 RA Weight Loss Drugs
Individualized ocular characteristics should be considered before starting GLP-1 RA therapies for weight loss and diabetes management.
bit.ly
May 20, 2025 at 6:16 PM
ophthalmologyadv.bsky.social
Is US Policy Failing Women?

Structural inequities in #HealthCareAccess have created disparities in #MaternalMortality in the United States.

Read more: bit.ly/3YurMIY

#MedSky #WomensHealth
Maternal Mortality: Is US Policy Failing Women?
Despite medical innovations, maternal mortality rates in the US remain high, especially compared with those of similarly wealthy countries.
bit.ly
April 25, 2025 at 5:25 PM
ophthalmologyadv.bsky.social
Ophthalmology Dx: This Little Pigment Tells The Whole Tale

A child with #PeripheralVision changes and #NightBlindness demonstrated unusual findings on #FundusAutofluorescence and #OCTImaging

Read more: bit.ly/42HQ1Vz

#EyeSky #MedSky
Ophthalmology Dx: This Little Pigment Tells The Whole Tale  - Ophthalmology Advisor
A child with peripheral vision changes and night blindness demonstrated some unusual findings on fundus autofluorescence and OCT imaging. Can you diagnose her?
bit.ly
April 24, 2025 at 7:45 PM
ophthalmologyadv.bsky.social
☔April's FDA Roundup

Here are the most recent trial findings, approvals, recalls and other notifications from the @fda.gov with regard to #Ophthalmology products.

Read more: bit.ly/40JLdPu

#MedSky #EyeSky
FDA Alerts: Ophthalmology Drug and Device Approvals
FDA alerts and updates on the latest drug and device approvals, recalls, and other regulatory developments in ophthalmology.
bit.ly
April 23, 2025 at 5:00 PM